Main Article Content
The article focuses on an actual problem of treating functional bowel diseases with clinical signs of dysbiosis in children. Objective of the study is assessment of effectiveness of comprehensive therapy with modern symbiotic containing strains Lactobacollus rhamnosus GG and fructooligosaccharides in irritable bowel syndrome children. Materials and methods. The study involves 35 children with irritable bowel syndrome and clinical manifestations of intestinal dysbiosis on the basis of subjective and objective symptoms, character of stool, coprogram and microbiological analysis of feces. Treatment efficacy is assessed taking into account the dynamics of the main symptoms of the disease (impaired stool, flatulence, loss of appetite, abdominal pain), normalization of coprogram indicators, results of the control microbiological analysis of feces. Objectification of the clinical manifestations of the disease is performed at baseline and before discharge of the child from hospital. Results. As a result of the developed schemes of treatment, the abdominal pain syndrome and symptoms of intestinal dyspepsia were quickly stopped. In children with skin manifestation of allergy, their severity has decreased. The clinical manifestations of the digestive disorders syndrome decreased, indicators of coprogram improved. A significant positive dynamics of fecal microbial composition is marked. More than a half of the patients achieve normalization of the quantitative composition of bifid bacteria and lactobacilli; the number of E.coli with altered enzymatic properties reduced, opportunistic and fungal flora was eliminated. The tolerability of prescribed treatment in all patients is good. Conclusions. Correction of intestinal biocenosis occupies an important place in the treatment of irritable bowel syndrome children. The study shows a high efficacy and safety of the combination of Lactobacollus rhamnosus GG and fructooligosaccharides in the comprehensive treatment of the disease that allows to recommend its practical application.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
Белоусова О.Ю. Дисбактериоз кишечника как фактор риска развития хронических заболеваний кишечника у детей / О.Ю. Белоусова // Здоровье ребенка. — 2011. — № 1(28). — С. 73-75.
Копанев Ю.А. Дисбактериоз кишечника: микробиологические, иммунологические аспекты микробиологических нарушений у детей / Ю.А. Копанев, А.Л. Соколов. — М., 2002. — 147 с.
Диагностика и тактика ведения детей с функциональными запорами / А.И. Хавкин, Р.А. Файзуллина, С.В. Бельмер [и др.] // Вопросы практической педиатрии. — 2014. — Т. 9, № 5. — С. 62-76.
Белоусова О.Ю. Алгоритм назначения пробиотиков у детей / О.Ю. Белоусова // Здоровье Украины. — 2015. — № 3(34). — С. 10-11.
Майданник В.Г. Антибиотико-ассоциированная диарея у детей / В.Г. Майданник. — К., 2013. — 38 с.
Recommendations for probiotic use — 2011 update / M.H. Floch, W.A. Walker, K. Madsen [et al.] // J. Clin. Gastroenterol. — 2011. — № 45. — Р. 168-171.
Ringel Y., Quigley E.M.M., Lin H.C. Using probiotics in gastrointestinal disorders / Y. Ringel, E.M.M. Quigley, H.C. Lin // Am. J. Gastroenterol. Suppl. — 2012. — № 1(1). — Р. 34-40.
Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants // A.L. Shane, M.D. Cabana, S. Vidry [et al.] // Gut Microbes. — 2010. — № 1(4). — Р. 243-253.
Whelan K., Myers C.E. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials / K. Whelan, C.E. Myers // Am. J. Clinc. Nutr. — 2010. — № 91(3). — Р. 687-703.
Horvath A., Dziechciarz P., Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood / A. Horvath, P. Dziechciarz, H. Szajewska // Aliment. Pharmacol. Ther. — 2011. — № 33(12). — Р. 1302-1310.